Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements
Tarang Sharma and colleagues argue for increased collaboration across public and private sectors—internationally and with patients—in drug assessment and managed entry agreements to support equitable and sustainable access to costly medicines
Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements — 科研速览 Science Skim